Holen Sie sich die Stockscreener-App
72.38
3.00%
2.0895
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$70.29
Offen:
$71.38
24-Stunden-Volumen:
132.40K
Relative Volume:
0.05
Marktkapitalisierung:
$14.12B
Einnahmen:
$4.23B
Nettoeinkommen (Verlust:
$235.80M
KGV:
61.13
EPS:
1.1841
Netto-Cashflow:
$569.50M
1W Leistung:
+1.96%
1M Leistung:
+1.94%
6M Leistung:
-10.04%
1J Leistung:
-0.70%
1-Tages-Spanne:
$71.06
$72.64
1-Wochen-Bereich:
$69.60
$72.64
52-Wochen-Spanne:
$58.89
$89.83
The Cooper Companies, Inc. Stock (COO) Company Profile
Firmenname
The Cooper Companies, Inc.
Sektor
Telefon
925-460-3600
Adresse
6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA
Compare COO vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COO
The Cooper Companies, Inc.
|
72.40 | 13.71B | 4.23B | 235.80M | 569.50M | 1.1841 |
ISRG
Intuitive Surgical Inc
|
366.64 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
166.45 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
41.01 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
69.31 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
208.51 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
The Cooper Companies, Inc. Stock (COO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-04 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-03 | Bestätigt | Needham | Buy |
| 2025-11-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Sell |
| 2025-08-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-22 | Hochstufung | BNP Paribas Exane | Neutral → Outperform |
| 2025-06-17 | Hochstufung | Needham | Hold → Buy |
| 2025-05-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-08-29 | Bestätigt | Piper Sandler | Overweight |
| 2024-07-16 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-19 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-03-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-30 | Eingeleitet | BofA Securities | Buy |
| 2023-10-05 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-05-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-30 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-12 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-05-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-04-08 | Eingeleitet | Needham | Hold |
| 2022-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-09-03 | Bestätigt | Citigroup | Neutral |
| 2021-09-03 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-09-03 | Bestätigt | Oppenheimer | Perform |
| 2021-09-03 | Bestätigt | Stifel | Buy |
| 2021-04-23 | Eingeleitet | Redburn | Buy |
| 2020-07-06 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2019-02-01 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-01-04 | Herabstufung | Goldman | Neutral → Sell |
| 2018-07-30 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-12-08 | Bestätigt | Stifel | Buy |
| 2017-09-12 | Bestätigt | Stifel | Buy |
| 2017-09-01 | Bestätigt | Piper Jaffray | Overweight |
| 2017-07-21 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-06-29 | Eingeleitet | Guggenheim | Neutral |
| 2017-06-02 | Bestätigt | Stifel | Buy |
| 2016-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2016-08-31 | Bestätigt | Stifel | Buy |
| 2016-06-30 | Bestätigt | Stifel | Buy |
| 2016-06-03 | Bestätigt | Jefferies | Buy |
| 2016-04-15 | Hochstufung | Jefferies | Hold → Buy |
| 2015-12-17 | Eingeleitet | Goldman | Neutral |
| 2015-12-04 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
The Cooper Companies, Inc. Aktie (COO) Neueste Nachrichten
UBS Initiates Cooper Companies at Neutral With $75 Price Target - marketscreener.com
Cooper Companies Inc (COO) Valuation: PE, PB & Fair Value Analysis - TradingKey
COO|Cooper Companies Inc|Price:70.300|Chg%:-0.010 - TradingKey
Cooper Companies Inc (COO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cooper Companies Inc (COO) Institutional Confidence - TradingKey
Cooper Companies Inc (COO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cooper Companies Inc (COO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cooper Companies Inc (COO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CooperCompanies stock steadies as contact lens growth supports earnings - Ad-hoc-news.de
Cooper Companies, Inc. Revenue Breakdown – FWB:CP60 - TradingView
Cooper Companies Inc (COO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cooper Companies Inc (COO) Cash Flow - TradingKey
COO|Cooper Companies Inc|Price:70.310|Chg%:+0.080 - TradingKey
Cooper Companies Inc (COO) Balance Sheet - TradingKey
The Cooper Companies, Inc. (CP60.DE) insider ownership and holdings - Yahoo Finance Singapore
Cooper Companies (COO) Stock Looks Weak On Returns Yet Rich On Earnings - Yahoo Finance
Did Cooper Companies' Q1 Beat Mask Underlying Weakness - Kavout | AI
CooperCompanies stock trades steadily as contact lens growth supports earnings - Ad-hoc-news.de
Cooper Companies Inc. R (CP60.DE) Q1 FY2026 earnings call transcript - Yahoo Finance
Cooper Companies, Inc. Revenue Breakdown – GETTEX:CP60 - TradingView
The Cooper Companies’ Q2 2026 Earnings: What to Expect - inkl
Cooper Companies Inc (COO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CooperCompanies stock steadies as investors weigh Vision and fertility growth - Ad-hoc-news.de
CooperCompanies stock trades steadily as vision care growth supports earnings - Ad-hoc-news.de
The Cooper Companies, Inc. (COO) Stock Analysis: Unpacking A 13.92% Potential Upside - DirectorsTalk Interviews
Reasons to retain Cooper Companies stock in your portfolio for now - MSN
CooperCompanies stock trades steadily as contact lens demand supports revenue growth - AD HOC NEWS
CooperCompanies stock trades steady as contact lens demand supports earnings momentum - Ad-hoc-news.de
The Cooper Companies, Inc. Stock 12‑Month Price Target Cut to $81.25, Implies 11% Upside - TradingView
CooperCompanies stock trades steady as recent earnings highlight growth in contact lenses and women� - AD HOC NEWS
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now - Yahoo Finance
CooperCompanies Releases 2025 Corporate Sustainability Report With Scope 3 Emissions Disclosure - VisionMonday.com
Pullback Created an Attractive Entry Point in The Cooper Companies (COO) - Yahoo Finance
Brown Advisory Sustainable Value Fund's The Cooper Companies Inc(COO) Holding History - GuruFocus
The Cooper Companies Inc (COO) Shares Fall 3.9% -- What GF Score of 89 Tells Investors - GuruFocus
Goldman Sachs Adjusts Price Target on Cooper Companies to $63 From $66, Maintains Sell Rating - Moomoo
CooperCompanies stock holds steady as a specialized medtech player with a global footprint - Ad-hoc-news.de
CooperCompanies stock stays supported by contact lens demand - Ad-hoc-news.de
Citi Maintains Cooper Companies(COO.US) With Hold Rating, Raises Target Price to $76 - Moomoo
CooperCompanies stock stays supported by steady medical demand - ad-hoc-news.de
CooperVision Strengthens Professional Affairs, Myopia Management Functions With Leadership Appointments - VisionMonday.com
A Look at The Cooper Companies Inc (COO) After 3.2% Decline -- G - GuruFocus
The Cooper Companies grows its healthcare footprint. Vision and fertility drive long-term demand - Ad-hoc-news.de
The Cooper Companies highlights eye care growth as investors watch US exposure - ad-hoc-news.de
CooperCompanies highlights specialty contact lenses as long-term demand driver - Ad-hoc-news.de
CooperVision Names Muru Annamalai as President, Asia-Pacific - AOL.com
CooperCompanies reports double-digit pay increase for its median employee - Medical Design & Outsourcing
The Cooper Companies updates investors. Medical devices group navigates vision care demand - Ad-hoc-news.de
CooperCompanies outlines growth plans as demand for vision care stays resilient - ad-hoc-news.de
CooperSurgical IVF LawsuitEmbryo Loss LawsuitJune 2026 - AboutLawsuits.com
Mid Value Fund's The Cooper Companies Inc(COO) Holding History - GuruFocus
Finanzdaten der The Cooper Companies, Inc.-Aktie (COO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):